Viewing nowKolon Glimepiride Tablets 2 mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.

MFDS item code 200606835 · Notified 2006.08.30 · Insurance code 670301520
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It primarily acts as an adjunct to dietary and exercise therapy and may also be used alone. If blood sugar control is not achieved with oral hypoglycemic agents, it may be combined with insulin. Additionally, if sufficient control cannot be achieved with sulfonylurea or metformin monotherapy, this medication can be administered in combination with metformin. It can be used in various situations to effectively improve blood sugar control.
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at 1 ~ 2-week intervals. Generally, there is little additional benefit at doses above 4 mg, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching to this medicine from another oral hypoglycemic agent There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previous medication. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. Hypoglycemia is generally controlled promptly by taking sugar. Hypoglycemia may recur even after it has initially been successfully managed during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodic adjustment of the insulin dose is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with type 1 diabetes who are using insulin, or in patients with diabetic ketoacidosis or coma. It should also be avoided in patients with allergies to this medication or its components, or in those with severe liver or kidney dysfunction. It is safest for women who are pregnant or breastfeeding to avoid this medication. In cases of severe infections or before and after surgery, insulin therapy is recommended. Caution should be taken in patients with gastrointestinal disorders, as absorption issues may increase the risk of hypoglycemia. This medication contains lactose, so it should not be administered to patients with lactose intolerance or specific genetic problems. During the first week of administration, there is a high risk of hypoglycemia, so blood sugar should be checked frequently and patients should be monitored closely. The risk of hypoglycemia increases especially in cases of irregular meals, nutritional deficiencies, excessive exercise, or alcohol consumption. Patients with reduced kidney or liver function, the elderly, or those taking other medications should also exercise caution. If symptoms of hypoglycemia occur, sugar should be ingested immediately, and in severe cases, medical assistance should be sought. This medication may cause various side effects including hypoglycemia, visual disturbances, nausea, vomiting, abdominal pain, liver dysfunction, blood disorders, and allergic reactions. Severe hypoglycemia can lead to loss of consciousness or coma, so caution is required. If unusual symptoms appear, patients should inform healthcare professionals immediately and consider discontinuing the medication. To control blood sugar, this medication should be taken alongside a consistent diet and exercise program; regular monitoring of blood sugar and liver and kidney function is necessary. This medication may interact with several other drugs, so patients should inform healthcare professionals if they are taking other medications. In the case of overdose, hypoglycemia may worsen, and immediate emergency treatment is required, which may include inducing vomiting, gastric lavage, and intravenous glucose administration. This medication should be kept out of the reach of children and stored in its original container. Women who are pregnant or breastfeeding should not use this medication, and if necessary, switching to insulin therapy is recommended. Its safety in children under 18 years has not been established, so it is not used in this age group. Dose adjustments may be necessary for the elderly due to potential decline in kidney function.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, diminished agility or energy, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, partial paralysis, sensory disturbance, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, phototoxic reactions of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness safely for a long time.
Green rectangular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.